Last updated: December 20, 2024
Sponsor: University of Jordan
Overall Status: Completed
Phase
3
Condition
Anxiety Disorders
Mood Disorders
Panic Disorders
Treatment
Diazepam
Placebo
Melatonin
Clinical Study ID
NCT06103188
M001
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ASA 1 or 2
Posted for general anesthesia
Aging between 18 and 65 years
Exclusion
Exclusion Criteria:
Allergy to any of the drugs under study
Pregnancy
Illiteracy
Any mental illness
Taking antipsychotics, antidepressants, anxiolytics, or sedatives
Study Design
Total Participants: 87
Treatment Group(s): 3
Primary Treatment: Diazepam
Phase: 3
Study Start date:
October 02, 2023
Estimated Completion Date:
October 30, 2023
Study Description
Connect with a study center
Jordan University Hospital
Amman,
JordanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.